PRNewsWire
02 Sept 2026, 11:36 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
cbdMD has entered a definitive agreement to acquire the operating assets and brands of Twinlab, including Reserveage and Metabolife. — The acquisition significantly expands the company's product portfolio and market reach into legacy supplements and sports nutrition.
+0.50The acquisition is expected to increase combined trailing twelve-month revenue to approximately $30 million, a 40% increase over cbdMD's standalone revenue. — Material top-line growth and scale expansion are generally viewed positively by investors.
+0.40The transaction is designed to reduce cbdMD's revenue concentration in the hemp category and mitigate regulatory risks associated with hemp-derived products. — Diversification away from a high-risk regulatory environment reduces the company's overall risk profile.
+0.30Continue reading
6 related stories
Search tags
The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval. — Court approval and ABC proceedings introduce execution risk and potential legal delays to the closing.
-0.20Which stocks this story touches
The company is expanding its product portfolio and diversifying revenue streams through the acquisition of Twinlab brands, expecting a 40% increase in revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Proactive Investors
8h ago
